Concepts (249)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| MicroRNAs | 6 | 2023 | 501 | 1.060 |
Why?
|
| Stomach Neoplasms | 2 | 2021 | 228 | 0.750 |
Why?
|
| Head and Neck Neoplasms | 1 | 2021 | 81 | 0.680 |
Why?
|
| Plant Growth Regulators | 1 | 2019 | 16 | 0.600 |
Why?
|
| Liver Neoplasms | 1 | 2021 | 211 | 0.590 |
Why?
|
| Gene Expression Regulation, Plant | 1 | 2019 | 65 | 0.580 |
Why?
|
| Vitis | 1 | 2019 | 37 | 0.580 |
Why?
|
| Plant Proteins | 1 | 2019 | 100 | 0.560 |
Why?
|
| Signal Transduction | 6 | 2025 | 2111 | 0.480 |
Why?
|
| Myocardial Infarction | 4 | 2025 | 242 | 0.480 |
Why?
|
| Selenoproteins | 3 | 2021 | 146 | 0.430 |
Why?
|
| Sequence Analysis, RNA | 5 | 2024 | 114 | 0.430 |
Why?
|
| Breast Neoplasms | 1 | 2023 | 1679 | 0.360 |
Why?
|
| Hypoxia-Inducible Factor 1 | 2 | 2021 | 12 | 0.320 |
Why?
|
| Organ Specificity | 2 | 2020 | 141 | 0.310 |
Why?
|
| Female | 23 | 2025 | 24018 | 0.310 |
Why?
|
| Prognosis | 3 | 2021 | 850 | 0.300 |
Why?
|
| Mice, Knockout | 5 | 2025 | 1010 | 0.300 |
Why?
|
| Chickens | 2 | 2021 | 148 | 0.300 |
Why?
|
| T-Lymphocytes | 2 | 2022 | 378 | 0.290 |
Why?
|
| Gene Expression Profiling | 3 | 2023 | 683 | 0.290 |
Why?
|
| Mice, Inbred C57BL | 8 | 2025 | 1804 | 0.260 |
Why?
|
| Mice | 13 | 2025 | 6490 | 0.260 |
Why?
|
| Male | 20 | 2025 | 22779 | 0.240 |
Why?
|
| Genes, Mitochondrial | 1 | 2025 | 14 | 0.240 |
Why?
|
| Animals | 18 | 2025 | 16695 | 0.230 |
Why?
|
| HIV Infections | 4 | 2020 | 2535 | 0.230 |
Why?
|
| Behavior, Animal | 2 | 2025 | 369 | 0.220 |
Why?
|
| Lactobacillus | 1 | 2024 | 22 | 0.220 |
Why?
|
| Humans | 21 | 2025 | 42163 | 0.220 |
Why?
|
| Vagina | 1 | 2024 | 89 | 0.220 |
Why?
|
| Tuberculosis | 1 | 2025 | 76 | 0.210 |
Why?
|
| Macrophages | 2 | 2025 | 515 | 0.210 |
Why?
|
| Myeloid Cells | 2 | 2024 | 31 | 0.210 |
Why?
|
| Zinc | 1 | 2025 | 130 | 0.210 |
Why?
|
| Pulmonary Fibrosis | 1 | 2024 | 38 | 0.210 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2025 | 106 | 0.210 |
Why?
|
| Alternative Splicing | 2 | 2021 | 92 | 0.210 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2025 | 188 | 0.200 |
Why?
|
| Pyruvate Kinase | 2 | 2025 | 18 | 0.200 |
Why?
|
| Epigenesis, Genetic | 1 | 2025 | 274 | 0.190 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2023 | 81 | 0.190 |
Why?
|
| Transcription, Genetic | 1 | 2025 | 599 | 0.190 |
Why?
|
| RNA | 2 | 2022 | 266 | 0.190 |
Why?
|
| Middle Aged | 10 | 2021 | 11819 | 0.190 |
Why?
|
| Exosomes | 1 | 2023 | 124 | 0.180 |
Why?
|
| Endometrium | 1 | 2022 | 60 | 0.180 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2021 | 21 | 0.180 |
Why?
|
| Mitochondria | 1 | 2025 | 516 | 0.180 |
Why?
|
| Relaxin | 1 | 2021 | 10 | 0.180 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2021 | 44 | 0.180 |
Why?
|
| Diet, Mediterranean | 1 | 2021 | 37 | 0.170 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2021 | 25 | 0.170 |
Why?
|
| Ethanolamine | 1 | 2021 | 5 | 0.170 |
Why?
|
| Adipocytes, Brown | 1 | 2021 | 8 | 0.170 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2021 | 55 | 0.170 |
Why?
|
| Thermogenesis | 1 | 2021 | 24 | 0.170 |
Why?
|
| Proteomics | 1 | 2023 | 363 | 0.170 |
Why?
|
| Myocardial Ischemia | 1 | 2021 | 82 | 0.170 |
Why?
|
| Up-Regulation | 2 | 2020 | 534 | 0.170 |
Why?
|
| Mixed Function Oxygenases | 1 | 2020 | 31 | 0.170 |
Why?
|
| Phospholipids | 1 | 2021 | 69 | 0.160 |
Why?
|
| DNA Methylation | 2 | 2025 | 393 | 0.160 |
Why?
|
| MAP Kinase Signaling System | 1 | 2022 | 189 | 0.160 |
Why?
|
| Pregnancy | 5 | 2025 | 1737 | 0.160 |
Why?
|
| Interferon Regulatory Factors | 1 | 2019 | 18 | 0.160 |
Why?
|
| Chromatin | 1 | 2021 | 179 | 0.160 |
Why?
|
| Central Nervous System Diseases | 1 | 2019 | 32 | 0.160 |
Why?
|
| Metabolome | 1 | 2019 | 50 | 0.160 |
Why?
|
| Cytoskeletal Proteins | 1 | 2020 | 114 | 0.150 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2021 | 158 | 0.150 |
Why?
|
| DNA-Binding Proteins | 2 | 2020 | 557 | 0.150 |
Why?
|
| Cytokinins | 1 | 2019 | 2 | 0.150 |
Why?
|
| Aged | 6 | 2021 | 7982 | 0.150 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2020 | 181 | 0.150 |
Why?
|
| Abscisic Acid | 1 | 2019 | 6 | 0.150 |
Why?
|
| Ethylenes | 1 | 2019 | 13 | 0.150 |
Why?
|
| Plant Shoots | 1 | 2019 | 25 | 0.150 |
Why?
|
| Dehydration | 1 | 2019 | 23 | 0.150 |
Why?
|
| Lyases | 1 | 2019 | 45 | 0.150 |
Why?
|
| Adenocarcinoma | 1 | 2021 | 287 | 0.150 |
Why?
|
| Genetic Markers | 1 | 2019 | 146 | 0.150 |
Why?
|
| Droughts | 1 | 2019 | 29 | 0.150 |
Why?
|
| Amino Acids | 1 | 2019 | 150 | 0.150 |
Why?
|
| Thioredoxins | 1 | 2019 | 36 | 0.150 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2018 | 22 | 0.150 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2021 | 290 | 0.150 |
Why?
|
| Diet | 1 | 2024 | 810 | 0.150 |
Why?
|
| Uterus | 1 | 2018 | 57 | 0.150 |
Why?
|
| Hypothalamus | 1 | 2019 | 121 | 0.140 |
Why?
|
| Bacteria | 1 | 2021 | 285 | 0.140 |
Why?
|
| Plant Leaves | 1 | 2019 | 134 | 0.140 |
Why?
|
| Egg Shell | 1 | 2018 | 35 | 0.140 |
Why?
|
| Antigens, CD | 1 | 2018 | 122 | 0.140 |
Why?
|
| Receptors, Cell Surface | 1 | 2018 | 146 | 0.140 |
Why?
|
| Leptin | 1 | 2019 | 118 | 0.140 |
Why?
|
| Lung Neoplasms | 2 | 2020 | 479 | 0.140 |
Why?
|
| Collagen Type XIII | 1 | 2017 | 1 | 0.140 |
Why?
|
| Urothelium | 1 | 2017 | 8 | 0.140 |
Why?
|
| Anti-Retroviral Agents | 1 | 2018 | 158 | 0.140 |
Why?
|
| Central Nervous System | 1 | 2018 | 150 | 0.130 |
Why?
|
| Insulin Resistance | 1 | 2019 | 199 | 0.130 |
Why?
|
| Collagen Type IV | 1 | 2017 | 48 | 0.130 |
Why?
|
| Obesity | 1 | 2025 | 1131 | 0.130 |
Why?
|
| Endemic Diseases | 1 | 2017 | 22 | 0.130 |
Why?
|
| Brain Injuries | 1 | 2018 | 133 | 0.130 |
Why?
|
| Antigens, Protozoan | 1 | 2017 | 74 | 0.130 |
Why?
|
| Plant Roots | 1 | 2019 | 180 | 0.130 |
Why?
|
| Antibodies, Protozoan | 1 | 2017 | 82 | 0.130 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2017 | 84 | 0.120 |
Why?
|
| Neoplasm Invasiveness | 1 | 2017 | 284 | 0.120 |
Why?
|
| Nerve Tissue Proteins | 1 | 2018 | 382 | 0.120 |
Why?
|
| Malaria, Falciparum | 1 | 2017 | 91 | 0.120 |
Why?
|
| Mutation | 2 | 2021 | 1169 | 0.120 |
Why?
|
| Antioxidants | 1 | 2019 | 439 | 0.120 |
Why?
|
| Protozoan Proteins | 1 | 2017 | 196 | 0.110 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2025 | 246 | 0.100 |
Why?
|
| Solar Energy | 1 | 2012 | 10 | 0.090 |
Why?
|
| Adult | 7 | 2024 | 13458 | 0.090 |
Why?
|
| Photons | 1 | 2012 | 29 | 0.090 |
Why?
|
| Fluorenes | 1 | 2012 | 26 | 0.090 |
Why?
|
| RNA, Ribosomal, 16S | 2 | 2024 | 190 | 0.090 |
Why?
|
| Disease Progression | 2 | 2025 | 661 | 0.090 |
Why?
|
| Disease Models, Animal | 3 | 2025 | 1554 | 0.090 |
Why?
|
| Myocardium | 2 | 2025 | 251 | 0.090 |
Why?
|
| Oviposition | 2 | 2021 | 14 | 0.080 |
Why?
|
| Computational Biology | 2 | 2023 | 324 | 0.080 |
Why?
|
| Metabolomics | 2 | 2021 | 90 | 0.080 |
Why?
|
| Young Adult | 4 | 2024 | 4936 | 0.080 |
Why?
|
| Neoplasms | 1 | 2020 | 1341 | 0.080 |
Why?
|
| Computer Simulation | 1 | 2012 | 404 | 0.080 |
Why?
|
| Glycolysis | 2 | 2021 | 71 | 0.080 |
Why?
|
| Embryo, Mammalian | 2 | 2022 | 158 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2020 | 933 | 0.070 |
Why?
|
| Models, Molecular | 1 | 2012 | 875 | 0.070 |
Why?
|
| Gene Regulatory Networks | 2 | 2019 | 143 | 0.070 |
Why?
|
| Cohort Studies | 2 | 2024 | 1729 | 0.070 |
Why?
|
| Monocytes | 2 | 2019 | 275 | 0.070 |
Why?
|
| Hawaii | 2 | 2024 | 2004 | 0.060 |
Why?
|
| RNA, Messenger | 2 | 2022 | 1265 | 0.060 |
Why?
|
| Reproducibility of Results | 2 | 2020 | 1058 | 0.060 |
Why?
|
| Thyroid Hormones | 1 | 2025 | 35 | 0.060 |
Why?
|
| Phagocytosis | 1 | 2025 | 83 | 0.060 |
Why?
|
| RNA, Small Nucleolar | 1 | 2023 | 4 | 0.050 |
Why?
|
| Interleukin-6 | 1 | 2025 | 165 | 0.050 |
Why?
|
| Models, Biological | 2 | 2018 | 711 | 0.050 |
Why?
|
| Hemolysis | 1 | 2023 | 59 | 0.050 |
Why?
|
| Fasting | 1 | 2023 | 56 | 0.050 |
Why?
|
| Host-Pathogen Interactions | 1 | 2025 | 203 | 0.050 |
Why?
|
| Sequence Alignment | 1 | 2023 | 273 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2024 | 180 | 0.050 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2022 | 14 | 0.050 |
Why?
|
| ets-Domain Protein Elk-1 | 1 | 2022 | 27 | 0.050 |
Why?
|
| Reactive Oxygen Species | 1 | 2025 | 518 | 0.050 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 2803 | 0.050 |
Why?
|
| Pregnancy Trimesters | 1 | 2021 | 15 | 0.050 |
Why?
|
| 3' Untranslated Regions | 1 | 2022 | 81 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2022 | 66 | 0.040 |
Why?
|
| Trisomy | 1 | 2021 | 11 | 0.040 |
Why?
|
| Eggs | 1 | 2021 | 14 | 0.040 |
Why?
|
| Philippines | 1 | 2021 | 80 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2021 | 30 | 0.040 |
Why?
|
| Oviducts | 1 | 2021 | 13 | 0.040 |
Why?
|
| Aneuploidy | 1 | 2021 | 24 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2022 | 310 | 0.040 |
Why?
|
| Ethanolamines | 1 | 2021 | 9 | 0.040 |
Why?
|
| Phosphatidylethanolamines | 1 | 2021 | 17 | 0.040 |
Why?
|
| Glycosylphosphatidylinositols | 1 | 2021 | 19 | 0.040 |
Why?
|
| Lipogenesis | 1 | 2021 | 19 | 0.040 |
Why?
|
| Biosynthetic Pathways | 1 | 2021 | 14 | 0.040 |
Why?
|
| RNA, Transfer, Amino Acid-Specific | 1 | 2021 | 13 | 0.040 |
Why?
|
| Lymphocyte Activation | 1 | 2022 | 244 | 0.040 |
Why?
|
| Cattle | 1 | 2022 | 505 | 0.040 |
Why?
|
| Fusobacteria | 1 | 2020 | 4 | 0.040 |
Why?
|
| Japan | 1 | 2021 | 348 | 0.040 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2021 | 71 | 0.040 |
Why?
|
| Meta-Analysis as Topic | 1 | 2020 | 34 | 0.040 |
Why?
|
| Adipose Tissue, Brown | 1 | 2021 | 39 | 0.040 |
Why?
|
| Microarray Analysis | 1 | 2020 | 64 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2021 | 168 | 0.040 |
Why?
|
| Databases, Genetic | 1 | 2020 | 103 | 0.040 |
Why?
|
| CD4-CD8 Ratio | 1 | 2019 | 30 | 0.040 |
Why?
|
| Pregnancy Complications | 1 | 2021 | 134 | 0.040 |
Why?
|
| Energy Metabolism | 1 | 2021 | 181 | 0.040 |
Why?
|
| Inflammation | 1 | 2025 | 729 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2020 | 362 | 0.040 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2019 | 200 | 0.040 |
Why?
|
| CpG Islands | 1 | 2019 | 107 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 438 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2021 | 658 | 0.040 |
Why?
|
| Blotting, Western | 1 | 2021 | 884 | 0.040 |
Why?
|
| Molting | 1 | 2018 | 8 | 0.040 |
Why?
|
| Genomics | 1 | 2021 | 289 | 0.040 |
Why?
|
| Grooming | 1 | 2018 | 5 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2025 | 990 | 0.040 |
Why?
|
| Disease-Free Survival | 1 | 2019 | 116 | 0.040 |
Why?
|
| Caenorhabditis elegans | 1 | 2019 | 78 | 0.040 |
Why?
|
| Microfilament Proteins | 1 | 2018 | 72 | 0.040 |
Why?
|
| Viral Load | 1 | 2019 | 344 | 0.040 |
Why?
|
| Autistic Disorder | 1 | 2018 | 38 | 0.040 |
Why?
|
| Adolescent | 2 | 2021 | 5950 | 0.040 |
Why?
|
| Selenium | 1 | 2019 | 150 | 0.030 |
Why?
|
| Isoenzymes | 1 | 2018 | 169 | 0.030 |
Why?
|
| Growth Hormone | 1 | 2017 | 35 | 0.030 |
Why?
|
| Cameroon | 1 | 2017 | 35 | 0.030 |
Why?
|
| Social Behavior | 1 | 2018 | 160 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2017 | 158 | 0.030 |
Why?
|
| Merozoite Surface Protein 1 | 1 | 2017 | 34 | 0.030 |
Why?
|
| Protein Binding | 1 | 2020 | 1076 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2018 | 452 | 0.030 |
Why?
|
| Interpersonal Relations | 1 | 2018 | 216 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2021 | 1617 | 0.030 |
Why?
|
| Base Sequence | 1 | 2018 | 997 | 0.030 |
Why?
|
| Immunoglobulin M | 1 | 2017 | 87 | 0.030 |
Why?
|
| Neural Tube | 1 | 2016 | 8 | 0.030 |
Why?
|
| Ectoderm | 1 | 2016 | 12 | 0.030 |
Why?
|
| Logistic Models | 1 | 2019 | 1001 | 0.030 |
Why?
|
| Codon, Nonsense | 1 | 2016 | 23 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 577 | 0.030 |
Why?
|
| Homozygote | 1 | 2016 | 77 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2019 | 1266 | 0.030 |
Why?
|
| Body Size | 1 | 2016 | 47 | 0.030 |
Why?
|
| Anti-HIV Agents | 1 | 2020 | 475 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2017 | 339 | 0.030 |
Why?
|
| Cell Polarity | 1 | 2016 | 55 | 0.030 |
Why?
|
| Estrogens | 1 | 2017 | 202 | 0.030 |
Why?
|
| Point Mutation | 1 | 2016 | 98 | 0.030 |
Why?
|
| Phenotype | 1 | 2018 | 774 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2019 | 1574 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2017 | 436 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2019 | 860 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2021 | 1420 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2016 | 255 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2016 | 303 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2017 | 1516 | 0.020 |
Why?
|
| Absorption | 1 | 2012 | 22 | 0.020 |
Why?
|
| Energy Transfer | 1 | 2012 | 32 | 0.020 |
Why?
|
| Photochemical Processes | 1 | 2012 | 19 | 0.020 |
Why?
|
| Aniline Compounds | 1 | 2012 | 27 | 0.020 |
Why?
|
| Biphenyl Compounds | 1 | 2012 | 52 | 0.020 |
Why?
|
| Carbazoles | 1 | 2012 | 46 | 0.020 |
Why?
|
| Fluorescence | 1 | 2012 | 113 | 0.020 |
Why?
|
| Quantum Theory | 1 | 2012 | 79 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2016 | 722 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2017 | 2598 | 0.020 |
Why?
|
| Algorithms | 1 | 2012 | 508 | 0.020 |
Why?
|
| Child | 1 | 2017 | 3381 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2017 | 3077 | 0.020 |
Why?
|
| United States | 1 | 2017 | 5072 | 0.020 |
Why?
|